Postimplant Phosphodiesterase Type 5 Inhibitors Use Is Associated With Lower Rates of Thrombotic Events After Left Ventricular Assist Device Implantation

BACKGROUND: Left ventricular assist device (LVAD) thrombosis is clinically devastating and impacts the cost effectiveness of LVAD therapy for advanced heart failure. Anticoagulation and antiplatelet therapies represent the standard of care to mitigate LVAD thrombosis. Phosphodiesterase type 5 inhibi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Am Heart Assoc
Prif Awduron: Xanthopoulos, Andrew, Tryposkiadis, Konstantinos, Triposkiadis, Filippos, Fukamachi, Kiyotaka, Soltesz, Edward G., Young, James B., Wolski, Kathy, Blackstone, Eugene H., Starling, Randall C.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2020
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7660717/
https://ncbi.nlm.nih.gov/pubmed/32648508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.015897
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg